https://www.selleckchem.com/pr....oducts/Gefitinib.htm
Objectives The purpose of this study was to evaluate the prognostic value of staging right heart failure (RHF) in patients with significant secondary tricuspid regurgitation (TR). Background Right ventricular dysfunction (RVD), defined as tricuspid annular plane systolic excursion less then 17 mm and clinical signs of RHF, defined as New York Heart Association functional class ≥II, peripheral edema, or use of diuretics, do not always coincide in patients with significant secondary TR and may have different prognostic implications. Met
Like
Comment
Share
